In human SCLC cell lines H146 and H345, TGF-β downregulates ASCL1 via a SMAD-dependent mechanism, suggesting its potential as a target for influencing SCLC phenotype transitions (85, 100). Here, ASCL1 is linked to small cell lung carcinoma.